CVI Holdings, LLC
CIK
1728194
Location
WILMINGTON, DE
Portfolio Value
Micro
$352,500
Diversification
Highly concentrated
Filing Date
Global Rank
#5,363
/ 7,299
▲ 80
Top Industry
Gambling
65.7%
3Y Alpha vs SPY
-48.7%
Period ended 1 year ago
Filed Aug 15, 2024 · 1y
18 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-62.5%
SPY
+76.5%
Annualised alpha
-48.7%
Max drawdown
−65.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
17 positions · as of Jun 30, 2024 · Δ vs Mar 31, 2024Top Position
65.7%
−12.1 pts
Top 5
85.8%
−7.3 pts
Top 10
96.1%
−3.9 pts
HHI
4,452
Highly concentrated−1,672
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Consumer Cyclical | 65.7% | $53,646,664 |
| Healthcare | 16.9% | $13,789,302 |
| Financial Services | 10.7% | $8,758,708 |
| Industrials | 3.9% | $3,182,004 |
| Consumer Defensive | 2.4% | $1,931,520 |
| Basic Materials | 0.4% | $352,500 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
3 positions
New Positions
Positions the filer opened this quarter
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | 679,739 | $5,444,709 | |
| INMB | Inmune Bio, Inc. | 596,372 | $5,260,001 | |
| AZZ | Azz Inc | 41,191 | $3,182,004 | |
| IBAC | IB Acquisition Corp. | 250,000 | $2,492,500 | |
| UCFI | CN Healthy Food Tech Group Corp. | 192,000 | $1,931,520 | |
| BAYA | Bayview Acquisition Corp | 143,732 | $1,471,815 | |
| NYXH | Nyxoah SA | 183,590 | $1,279,622 | |
| SRZN | Surrozen, Inc./DE | 64,905 | $710,709 | |
| TARA | Protara Therapeutics, Inc. | 302,746 | $629,711 | |
| GROY | Gold Royalty Corp. | 250,000 | $352,500 | |
| NXL | Nexalin Technology, Inc. | 55,462 | $93,730 | |
| LXRX | Lexicon Pharmaceuticals, Inc. | 20,000 | $33,600 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SPIR | Spire Global, Inc. | 260,929 | $3,131,148 | |
| ERAS | Erasca, Inc. | 1,456,311 | $3,000,000 | |
| ONDS | Ondas Inc. | 1,148,556 | $1,114,099 | |
| TRNO | Terreno Realty Corp | 15,000 | $996,000 | |
| ALCYF | Alchemy Investments Acquisition Corp 1 | 22,410 | $237,097 | |
| ESPR | Esperion Therapeutics, Inc. | 13,734 | $36,807 | |
| No positions match the current search. | ||||
1 positions ·
$352,500 total
· Basic Materials only
· as of Jun 30, 2024
All sectors
Basic Materials
Consumer Cyclical
Consumer Defensive
Financial Services
Healthcare
Industrials
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GROY |
Gold Royalty Corp.
Basic Materials
|
NEW | 250,000 | $352,500 | 100.00% |